Katsuhisa Ioriya

Title: Katsuhisa Ioriya: Innovator in Naphthyridine Derivatives

Introduction

Katsuhisa Ioriya is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on naphthyridine derivatives. His research focuses on compounds that have potential applications in treating various health conditions.

Latest Patents

Katsuhisa Ioriya holds a patent for naphthyridine derivatives, specifically a compound that exhibits acyl-CoA: cholesterol acyl transferase inhibitory activity. This compound is characterized by a formula where Ring A is substituted or unsubstituted pyridine, and it includes various substituents that enhance its therapeutic potential. The patent highlights the compound's usefulness in the prophylaxis or treatment of hyperlipidemia, atherosclerosis, and related diseases. He has 1 patent to his name.

Career Highlights

Ioriya is associated with Sumitomo Pharmaceuticals Company Limited, where he has been able to apply his expertise in pharmaceutical innovation. His work has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Throughout his career, Katsuhisa Ioriya has collaborated with esteemed colleagues, including Hideki Yagi and Naohito Ohashi. These collaborations have fostered a productive environment for research and innovation.

Conclusion

Katsuhisa Ioriya's contributions to the field of pharmaceuticals, particularly through his patent on naphthyridine derivatives, underscore his role as an innovator. His work continues to have implications for the treatment of significant health issues.